This phenomenon of p16 and p53 “double positivity” is common in some tumour types, such as tubo-ovarian high-grade serous carcinoma but has in addition been described at body sites where HPV-A SCCs occur [15, 18, 20, 21, 32]. The gene discussed is CDKN2A; the disease is neoplasm.